Literature DB >> 11706741

Multiple endocrine neoplasia type 1.

M L Brandi1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11706741     DOI： 10.1023/a:1026562217102

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  34 in total

1.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

2.  Lethality of multiple endocrine neoplasia type I.

Authors:  G M Doherty; J A Olson; M M Frisella; T C Lairmore; S A Wells; J A Norton
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

3.  Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.

Authors:  C Bordi; A Falchetti; C Azzoni; T D'Adda; G Canavese; A Guariglia; D Santini; P Tomassetti; M L Brandi
Journal:  Am J Surg Pathol       Date:  1997-09       Impact factor: 6.394

4.  Partially reversible osteopenia after surgery for primary hyperparathyroidism.

Authors:  P Martin; P Bergmann; C Gillet; M Fuss; P Kinnaert; J Corvilain; J van Geertruyden
Journal:  Arch Intern Med       Date:  1986-04

Review 5.  Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.

Authors:  R A DeLellis
Journal:  Lab Invest       Date:  1995-05       Impact factor: 5.662

6.  Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

Authors:  C M Pfarr; F Mechta; G Spyrou; D Lallemand; S Carillo; M Yaniv
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

7.  Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.

Authors:  T N Darling; M C Skarulis; S M Steinberg; S J Marx; A M Spiegel; M Turner
Journal:  Arch Dermatol       Date:  1997-07

Review 8.  Multiple endocrine neoplasia type 1 and 2: from morphology to molecular pathology 1997.

Authors:  P Komminoth
Journal:  Verh Dtsch Ges Pathol       Date:  1997

9.  Characterization of the mouse Men1 gene and its expression during development.

Authors:  C Stewart; F Parente; F Piehl; F Farnebo; D Quincey; G Silins; L Bergman; G F Carle; I Lemmens; S Grimmond; C Z Xian; S Khodei; B T Teh; J Lagercrantz; P Siggers; A Calender; V Van de Vem; K Kas; G Weber; N Hayward; P Gaudray; C Larsson
Journal:  Oncogene       Date:  1998-11-12       Impact factor: 9.867

Review 10.  Long-term health risk of primary hyperparathyroidism: the effect of surgery.

Authors:  A Sivula; R Pelkonen
Journal:  Ann Med       Date:  1996-04       Impact factor: 4.709
View more
  5 in total

1.  MEN1 family with a novel frameshift mutation.

Authors:  V Nuzzo; L Tauchmanová; A Falchetti; A Faggiano; F Marini; S Piantadosi; M L Brandi; L Leopaldi; A Colao
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

2.  Conditional deletion of menin results in antral G cell hyperplasia and hypergastrinemia.

Authors:  Natalia A Veniaminova; Michael M Hayes; Jessica M Varney; Juanita L Merchant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-07-05       Impact factor: 4.052

3.  Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1.

Authors:  Caroline L Lopez; Max B Albers; Carmen Bollmann; Jerena Manoharan; Jens Waldmann; Volker Fendrich; Detlef K Bartsch
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

4.  Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.

Authors:  V Polenta; E P Slater; P H Kann; M B Albers; J Manoharan; A Ramaswamy; A H Mahnken; D K Bartsch
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

5.  One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study.

Authors:  Niki Christou; Muriel Mathonnet; Sébastien Gaujoux; Guillaume Cadiot; Sophie Deguelte; Jean-Louis Kraimps; Jean-Christophe Lifante; Fabrice Menegaux; Eric Mirallié; Fabrice Muscari; Bruno Carnaille; François Pattou; Alain Sauvanet; Pierre Goudet
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.